赛尔图因的见解:弥合细胞过程和治疗应用之间的差距
Shagufta Kamal1, Sharon Babar1, Waqas Ali1
1Department of Biochemistry, Government College University, Faisalabad, Pakistan.
Naunyn-Schmiedeberg's archives of pharmacology
|July 8, 2024
概括
赛尔图因 (SIRT) 是依赖NAD+的酶,对细胞过程和癌症等疾病至关重要. 了解它们作为癌症促进剂或抑制剂的作用以及化合物如何影响它们,为新的治疗策略提供了新的机会.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 生物体面临环境变化,压力和代谢波动的挑战,往往导致病理状况,特别是癌症.
- 赛尔图因 (SIRTs) 是一类依赖NAD+的酶,在细胞过程中起着至关重要的作用,并与各种疾病有关.
- SIRT异形的多样性功能和基质特异性突出显示了它们在正常细胞功能和疾病发病过程中的重要性.
研究的目的:
- 详细说明SIRT异型在癌症中的不同作用,确定它们是潜在的促进者或抑制者.
- 探索天然和合成化合物对SIRT功能的影响,用于治疗应用.
- 提供SIRT的全面概述,将它们与疾病联系起来,以及它们在向治疗和个性化医学中的潜力.
主要方法:
- 文献综述和对SIRT异型的现有研究的综合.
- 对研究自然和合成化合物对SIRT活性影响的研究分析.
- 探索有关SIRT参与各种病理状况,包括癌症的数据.
主要成果:
- 在癌症中,SIRT异型表现出双重作用,根据上下文,它们可以作为促进剂或抑制剂.
- 自然和合成化合物在调节SIRT功能方面表现出潜力,这表明了治疗途径.
- 较少研究的SIRT异型,如SIRT6和SIRT7,具有独特的功能,需要进一步研究.
结论:
- 赛尔图因是细胞过程和疾病,特别是癌症的关键调节者.
- 使用特定的抑制剂或激活剂向调节SIRT活性,有望治疗未满足需求的疾病.
- 对SIRT异形及其与化合物的相互作用的进一步研究可以推动创新的治疗策略和个性化医学.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Mitochondria
12.0K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.0K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K


